nodes	percent_of_prediction	percent_of_DWPC	metapath
Atomoxetine—Diphenhydramine—atopic dermatitis	0.437	1	CrCtD
Atomoxetine—Reboxetine—Diphenhydramine—atopic dermatitis	0.0341	0.101	CrCrCtD
Atomoxetine—Benzatropine—Dimenhydrinate—atopic dermatitis	0.0288	0.0848	CrCrCtD
Atomoxetine—Diphenylpyraline—Dimenhydrinate—atopic dermatitis	0.0203	0.0598	CrCrCtD
Atomoxetine—Modafinil—Dimenhydrinate—atopic dermatitis	0.0198	0.0585	CrCrCtD
Atomoxetine—Bromodiphenhydramine—Dimenhydrinate—atopic dermatitis	0.019	0.0559	CrCrCtD
Atomoxetine—Cyclizine—Dimenhydrinate—atopic dermatitis	0.0182	0.0536	CrCrCtD
Atomoxetine—Warfarin—Diphenhydramine—atopic dermatitis	0.0168	0.0494	CrCrCtD
Atomoxetine—Orphenadrine—Dimenhydrinate—atopic dermatitis	0.0149	0.0439	CrCrCtD
Atomoxetine—CYP3A4—Pimecrolimus—atopic dermatitis	0.0147	0.124	CbGbCtD
Atomoxetine—Phenprocoumon—Diphenhydramine—atopic dermatitis	0.0142	0.0417	CrCrCtD
Atomoxetine—Benzatropine—Diphenhydramine—atopic dermatitis	0.0137	0.0402	CrCrCtD
Atomoxetine—Diphenhydramine—Dimenhydrinate—atopic dermatitis	0.0132	0.039	CrCrCtD
Atomoxetine—CYP2C19—Loratadine—atopic dermatitis	0.0132	0.111	CbGbCtD
Atomoxetine—CYP2C19—Diphenhydramine—atopic dermatitis	0.0132	0.111	CbGbCtD
Atomoxetine—Eprazinone—Diphenhydramine—atopic dermatitis	0.0127	0.0375	CrCrCtD
Atomoxetine—Fenoprofen—Diphenhydramine—atopic dermatitis	0.0109	0.0322	CrCrCtD
Atomoxetine—Doxylamine—Diphenhydramine—atopic dermatitis	0.0107	0.0314	CrCrCtD
Atomoxetine—Phenoxybenzamine—Diphenhydramine—atopic dermatitis	0.0101	0.0298	CrCrCtD
Atomoxetine—CYP2D6—Loratadine—atopic dermatitis	0.0101	0.0846	CbGbCtD
Atomoxetine—CYP2D6—Diphenhydramine—atopic dermatitis	0.0101	0.0846	CbGbCtD
Atomoxetine—Diphenylpyraline—Diphenhydramine—atopic dermatitis	0.00964	0.0284	CrCrCtD
Atomoxetine—Modafinil—Diphenhydramine—atopic dermatitis	0.00942	0.0277	CrCrCtD
Atomoxetine—Bromodiphenhydramine—Diphenhydramine—atopic dermatitis	0.00901	0.0265	CrCrCtD
Atomoxetine—Pheniramine—Diphenhydramine—atopic dermatitis	0.00882	0.026	CrCrCtD
Atomoxetine—CYP3A4—Tacrolimus—atopic dermatitis	0.00874	0.0735	CbGbCtD
Atomoxetine—Cyclizine—Diphenhydramine—atopic dermatitis	0.00864	0.0254	CrCrCtD
Atomoxetine—Methadone—Diphenhydramine—atopic dermatitis	0.00846	0.0249	CrCrCtD
Atomoxetine—CYP2C19—Prednisone—atopic dermatitis	0.00733	0.0616	CbGbCtD
Atomoxetine—Clofedanol—Diphenhydramine—atopic dermatitis	0.00731	0.0215	CrCrCtD
Atomoxetine—Orphenadrine—Diphenhydramine—atopic dermatitis	0.00708	0.0209	CrCrCtD
Atomoxetine—Benzphetamine—Diphenhydramine—atopic dermatitis	0.00708	0.0209	CrCrCtD
Atomoxetine—Benzyl Benzoate—Diphenhydramine—atopic dermatitis	0.00656	0.0193	CrCrCtD
Atomoxetine—CYP3A4—Loratadine—atopic dermatitis	0.0064	0.0538	CbGbCtD
Atomoxetine—CYP3A4—Methylprednisolone—atopic dermatitis	0.00585	0.0492	CbGbCtD
Atomoxetine—CYP2C19—Dexamethasone—atopic dermatitis	0.00458	0.0385	CbGbCtD
Atomoxetine—CYP3A4—Triamcinolone—atopic dermatitis	0.00444	0.0373	CbGbCtD
Atomoxetine—CYP3A4—Betamethasone—atopic dermatitis	0.00381	0.032	CbGbCtD
Atomoxetine—CYP3A4—Prednisolone—atopic dermatitis	0.00375	0.0315	CbGbCtD
Atomoxetine—CYP3A4—Hydrocortisone—atopic dermatitis	0.00356	0.0299	CbGbCtD
Atomoxetine—CYP3A4—Prednisone—atopic dermatitis	0.00355	0.0298	CbGbCtD
Atomoxetine—CYP2D6—Dexamethasone—atopic dermatitis	0.00348	0.0292	CbGbCtD
Atomoxetine—CYP3A4—Dexamethasone—atopic dermatitis	0.00221	0.0186	CbGbCtD
Atomoxetine—Pseudoephedrine—IL2—atopic dermatitis	0.000499	0.561	CrCbGaD
Atomoxetine—Ketoprofen—CXCL8—atopic dermatitis	0.000222	0.25	CrCbGaD
Atomoxetine—Pseudoephedrine—TNF—atopic dermatitis	0.000168	0.189	CrCbGaD
Atomoxetine—Cardiac disorder—Methylprednisolone—atopic dermatitis	5.83e-05	0.000716	CcSEcCtD
Atomoxetine—Malnutrition—Hydrocortisone—atopic dermatitis	5.82e-05	0.000715	CcSEcCtD
Atomoxetine—Erectile dysfunction—Prednisone—atopic dermatitis	5.72e-05	0.000703	CcSEcCtD
Atomoxetine—Angiopathy—Methylprednisolone—atopic dermatitis	5.69e-05	0.0007	CcSEcCtD
Atomoxetine—Hallucination—Betamethasone—atopic dermatitis	5.68e-05	0.000698	CcSEcCtD
Atomoxetine—Hallucination—Dexamethasone—atopic dermatitis	5.68e-05	0.000698	CcSEcCtD
Atomoxetine—Nausea—Mometasone—atopic dermatitis	5.68e-05	0.000698	CcSEcCtD
Atomoxetine—Mediastinal disorder—Methylprednisolone—atopic dermatitis	5.66e-05	0.000695	CcSEcCtD
Atomoxetine—Weight decreased—Prednisone—atopic dermatitis	5.62e-05	0.000691	CcSEcCtD
Atomoxetine—Vision blurred—Prednisolone—atopic dermatitis	5.61e-05	0.00069	CcSEcCtD
Atomoxetine—Depression—Prednisone—atopic dermatitis	5.52e-05	0.000679	CcSEcCtD
Atomoxetine—Mental disorder—Methylprednisolone—atopic dermatitis	5.5e-05	0.000676	CcSEcCtD
Atomoxetine—Malnutrition—Methylprednisolone—atopic dermatitis	5.46e-05	0.000672	CcSEcCtD
Atomoxetine—Asthenia—Tacrolimus—atopic dermatitis	5.46e-05	0.000671	CcSEcCtD
Atomoxetine—Pruritus—Tacrolimus—atopic dermatitis	5.38e-05	0.000662	CcSEcCtD
Atomoxetine—Dysgeusia—Triamcinolone—atopic dermatitis	5.36e-05	0.000659	CcSEcCtD
Atomoxetine—Vertigo—Prednisolone—atopic dermatitis	5.35e-05	0.000658	CcSEcCtD
Atomoxetine—Syncope—Prednisolone—atopic dermatitis	5.34e-05	0.000656	CcSEcCtD
Atomoxetine—Back pain—Triamcinolone—atopic dermatitis	5.3e-05	0.000651	CcSEcCtD
Atomoxetine—Loss of consciousness—Prednisolone—atopic dermatitis	5.23e-05	0.000643	CcSEcCtD
Atomoxetine—Vertigo—Hydrocortisone—atopic dermatitis	5.22e-05	0.000642	CcSEcCtD
Atomoxetine—Syncope—Hydrocortisone—atopic dermatitis	5.22e-05	0.000641	CcSEcCtD
Atomoxetine—Diarrhoea—Tacrolimus—atopic dermatitis	5.21e-05	0.00064	CcSEcCtD
Atomoxetine—Angiopathy—Dexamethasone—atopic dermatitis	5.18e-05	0.000637	CcSEcCtD
Atomoxetine—Angiopathy—Betamethasone—atopic dermatitis	5.18e-05	0.000637	CcSEcCtD
Atomoxetine—Convulsion—Prednisolone—atopic dermatitis	5.16e-05	0.000634	CcSEcCtD
Atomoxetine—Loss of consciousness—Hydrocortisone—atopic dermatitis	5.11e-05	0.000628	CcSEcCtD
Atomoxetine—Convulsion—Hydrocortisone—atopic dermatitis	5.04e-05	0.000619	CcSEcCtD
Atomoxetine—Dizziness—Tacrolimus—atopic dermatitis	5.03e-05	0.000619	CcSEcCtD
Atomoxetine—Myalgia—Hydrocortisone—atopic dermatitis	4.95e-05	0.000609	CcSEcCtD
Atomoxetine—Hallucination—Prednisone—atopic dermatitis	4.95e-05	0.000608	CcSEcCtD
Atomoxetine—Anxiety—Hydrocortisone—atopic dermatitis	4.93e-05	0.000607	CcSEcCtD
Atomoxetine—Vertigo—Triamcinolone—atopic dermatitis	4.92e-05	0.000605	CcSEcCtD
Atomoxetine—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	4.92e-05	0.000604	CcSEcCtD
Atomoxetine—Syncope—Triamcinolone—atopic dermatitis	4.91e-05	0.000604	CcSEcCtD
Atomoxetine—Vertigo—Methylprednisolone—atopic dermatitis	4.91e-05	0.000603	CcSEcCtD
Atomoxetine—Syncope—Methylprednisolone—atopic dermatitis	4.9e-05	0.000602	CcSEcCtD
Atomoxetine—Vomiting—Tacrolimus—atopic dermatitis	4.84e-05	0.000595	CcSEcCtD
Atomoxetine—Loss of consciousness—Triamcinolone—atopic dermatitis	4.81e-05	0.000592	CcSEcCtD
Atomoxetine—Loss of consciousness—Methylprednisolone—atopic dermatitis	4.8e-05	0.00059	CcSEcCtD
Atomoxetine—Rash—Tacrolimus—atopic dermatitis	4.8e-05	0.00059	CcSEcCtD
Atomoxetine—Dermatitis—Tacrolimus—atopic dermatitis	4.79e-05	0.000589	CcSEcCtD
Atomoxetine—Shock—Prednisolone—atopic dermatitis	4.78e-05	0.000588	CcSEcCtD
Atomoxetine—Cough—Triamcinolone—atopic dermatitis	4.78e-05	0.000587	CcSEcCtD
Atomoxetine—Headache—Tacrolimus—atopic dermatitis	4.77e-05	0.000586	CcSEcCtD
Atomoxetine—Convulsion—Triamcinolone—atopic dermatitis	4.74e-05	0.000583	CcSEcCtD
Atomoxetine—Tachycardia—Prednisolone—atopic dermatitis	4.74e-05	0.000583	CcSEcCtD
Atomoxetine—Convulsion—Methylprednisolone—atopic dermatitis	4.73e-05	0.000582	CcSEcCtD
Atomoxetine—Infection—Hydrocortisone—atopic dermatitis	4.72e-05	0.00058	CcSEcCtD
Atomoxetine—Hyperhidrosis—Prednisolone—atopic dermatitis	4.7e-05	0.000578	CcSEcCtD
Atomoxetine—Shock—Hydrocortisone—atopic dermatitis	4.67e-05	0.000574	CcSEcCtD
Atomoxetine—Myalgia—Triamcinolone—atopic dermatitis	4.66e-05	0.000573	CcSEcCtD
Atomoxetine—Nervous system disorder—Hydrocortisone—atopic dermatitis	4.65e-05	0.000572	CcSEcCtD
Atomoxetine—Arthralgia—Methylprednisolone—atopic dermatitis	4.65e-05	0.000572	CcSEcCtD
Atomoxetine—Myalgia—Methylprednisolone—atopic dermatitis	4.65e-05	0.000572	CcSEcCtD
Atomoxetine—Anxiety—Methylprednisolone—atopic dermatitis	4.64e-05	0.00057	CcSEcCtD
Atomoxetine—Tachycardia—Hydrocortisone—atopic dermatitis	4.63e-05	0.000569	CcSEcCtD
Atomoxetine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	4.62e-05	0.000568	CcSEcCtD
Atomoxetine—Flushing—Prednisone—atopic dermatitis	4.61e-05	0.000567	CcSEcCtD
Atomoxetine—Skin disorder—Hydrocortisone—atopic dermatitis	4.61e-05	0.000567	CcSEcCtD
Atomoxetine—Hyperhidrosis—Hydrocortisone—atopic dermatitis	4.59e-05	0.000564	CcSEcCtD
Atomoxetine—Dry mouth—Triamcinolone—atopic dermatitis	4.56e-05	0.000561	CcSEcCtD
Atomoxetine—Anorexia—Hydrocortisone—atopic dermatitis	4.52e-05	0.000556	CcSEcCtD
Atomoxetine—Nausea—Tacrolimus—atopic dermatitis	4.52e-05	0.000556	CcSEcCtD
Atomoxetine—Angiopathy—Prednisone—atopic dermatitis	4.51e-05	0.000554	CcSEcCtD
Atomoxetine—Vertigo—Dexamethasone—atopic dermatitis	4.46e-05	0.000549	CcSEcCtD
Atomoxetine—Vertigo—Betamethasone—atopic dermatitis	4.46e-05	0.000549	CcSEcCtD
Atomoxetine—Syncope—Dexamethasone—atopic dermatitis	4.46e-05	0.000548	CcSEcCtD
Atomoxetine—Syncope—Betamethasone—atopic dermatitis	4.46e-05	0.000548	CcSEcCtD
Atomoxetine—Infection—Triamcinolone—atopic dermatitis	4.44e-05	0.000546	CcSEcCtD
Atomoxetine—Infection—Methylprednisolone—atopic dermatitis	4.43e-05	0.000545	CcSEcCtD
Atomoxetine—Shock—Triamcinolone—atopic dermatitis	4.4e-05	0.000541	CcSEcCtD
Atomoxetine—Insomnia—Prednisolone—atopic dermatitis	4.4e-05	0.00054	CcSEcCtD
Atomoxetine—Shock—Methylprednisolone—atopic dermatitis	4.39e-05	0.000539	CcSEcCtD
Atomoxetine—Nervous system disorder—Methylprednisolone—atopic dermatitis	4.37e-05	0.000538	CcSEcCtD
Atomoxetine—Loss of consciousness—Betamethasone—atopic dermatitis	4.37e-05	0.000537	CcSEcCtD
Atomoxetine—Loss of consciousness—Dexamethasone—atopic dermatitis	4.37e-05	0.000537	CcSEcCtD
Atomoxetine—Paraesthesia—Prednisolone—atopic dermatitis	4.36e-05	0.000536	CcSEcCtD
Atomoxetine—Tachycardia—Triamcinolone—atopic dermatitis	4.36e-05	0.000536	CcSEcCtD
Atomoxetine—Mental disorder—Prednisone—atopic dermatitis	4.35e-05	0.000535	CcSEcCtD
Atomoxetine—Tachycardia—Methylprednisolone—atopic dermatitis	4.35e-05	0.000535	CcSEcCtD
Atomoxetine—Skin disorder—Methylprednisolone—atopic dermatitis	4.33e-05	0.000532	CcSEcCtD
Atomoxetine—Malnutrition—Prednisone—atopic dermatitis	4.33e-05	0.000532	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	4.32e-05	0.000532	CcSEcCtD
Atomoxetine—Hyperhidrosis—Triamcinolone—atopic dermatitis	4.32e-05	0.000531	CcSEcCtD
Atomoxetine—Hyperhidrosis—Methylprednisolone—atopic dermatitis	4.31e-05	0.00053	CcSEcCtD
Atomoxetine—Convulsion—Dexamethasone—atopic dermatitis	4.3e-05	0.000529	CcSEcCtD
Atomoxetine—Convulsion—Betamethasone—atopic dermatitis	4.3e-05	0.000529	CcSEcCtD
Atomoxetine—Insomnia—Hydrocortisone—atopic dermatitis	4.29e-05	0.000528	CcSEcCtD
Atomoxetine—Paraesthesia—Hydrocortisone—atopic dermatitis	4.26e-05	0.000524	CcSEcCtD
Atomoxetine—Myalgia—Betamethasone—atopic dermatitis	4.23e-05	0.00052	CcSEcCtD
Atomoxetine—Myalgia—Dexamethasone—atopic dermatitis	4.23e-05	0.00052	CcSEcCtD
Atomoxetine—Anxiety—Betamethasone—atopic dermatitis	4.22e-05	0.000518	CcSEcCtD
Atomoxetine—Anxiety—Dexamethasone—atopic dermatitis	4.22e-05	0.000518	CcSEcCtD
Atomoxetine—Dyspepsia—Hydrocortisone—atopic dermatitis	4.18e-05	0.000514	CcSEcCtD
Atomoxetine—Pain—Prednisolone—atopic dermatitis	4.16e-05	0.000511	CcSEcCtD
Atomoxetine—Decreased appetite—Hydrocortisone—atopic dermatitis	4.13e-05	0.000507	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	4.1e-05	0.000504	CcSEcCtD
Atomoxetine—Fatigue—Hydrocortisone—atopic dermatitis	4.09e-05	0.000503	CcSEcCtD
Atomoxetine—Vision blurred—Prednisone—atopic dermatitis	4.08e-05	0.000501	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	4.07e-05	0.000501	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	4.06e-05	0.000499	CcSEcCtD
Atomoxetine—Pain—Hydrocortisone—atopic dermatitis	4.06e-05	0.000499	CcSEcCtD
Atomoxetine—Insomnia—Triamcinolone—atopic dermatitis	4.04e-05	0.000497	CcSEcCtD
Atomoxetine—Insomnia—Methylprednisolone—atopic dermatitis	4.03e-05	0.000496	CcSEcCtD
Atomoxetine—Infection—Dexamethasone—atopic dermatitis	4.03e-05	0.000495	CcSEcCtD
Atomoxetine—Infection—Betamethasone—atopic dermatitis	4.03e-05	0.000495	CcSEcCtD
Atomoxetine—Paraesthesia—Triamcinolone—atopic dermatitis	4.01e-05	0.000493	CcSEcCtD
Atomoxetine—Feeling abnormal—Prednisolone—atopic dermatitis	4e-05	0.000492	CcSEcCtD
Atomoxetine—Paraesthesia—Methylprednisolone—atopic dermatitis	4e-05	0.000492	CcSEcCtD
Atomoxetine—Shock—Betamethasone—atopic dermatitis	3.99e-05	0.00049	CcSEcCtD
Atomoxetine—Shock—Dexamethasone—atopic dermatitis	3.99e-05	0.00049	CcSEcCtD
Atomoxetine—Nervous system disorder—Dexamethasone—atopic dermatitis	3.98e-05	0.000489	CcSEcCtD
Atomoxetine—Nervous system disorder—Betamethasone—atopic dermatitis	3.98e-05	0.000489	CcSEcCtD
Atomoxetine—Agitation—Prednisone—atopic dermatitis	3.98e-05	0.000489	CcSEcCtD
Atomoxetine—Tachycardia—Betamethasone—atopic dermatitis	3.96e-05	0.000487	CcSEcCtD
Atomoxetine—Tachycardia—Dexamethasone—atopic dermatitis	3.96e-05	0.000487	CcSEcCtD
Atomoxetine—Dyspepsia—Triamcinolone—atopic dermatitis	3.93e-05	0.000484	CcSEcCtD
Atomoxetine—Dyspepsia—Methylprednisolone—atopic dermatitis	3.93e-05	0.000483	CcSEcCtD
Atomoxetine—Hyperhidrosis—Betamethasone—atopic dermatitis	3.92e-05	0.000482	CcSEcCtD
Atomoxetine—Hyperhidrosis—Dexamethasone—atopic dermatitis	3.92e-05	0.000482	CcSEcCtD
Atomoxetine—Feeling abnormal—Hydrocortisone—atopic dermatitis	3.91e-05	0.000481	CcSEcCtD
Atomoxetine—Vertigo—Prednisone—atopic dermatitis	3.89e-05	0.000478	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	3.88e-05	0.000477	CcSEcCtD
Atomoxetine—Syncope—Prednisone—atopic dermatitis	3.88e-05	0.000477	CcSEcCtD
Atomoxetine—Anorexia—Dexamethasone—atopic dermatitis	3.87e-05	0.000475	CcSEcCtD
Atomoxetine—Anorexia—Betamethasone—atopic dermatitis	3.87e-05	0.000475	CcSEcCtD
Atomoxetine—Urticaria—Prednisolone—atopic dermatitis	3.86e-05	0.000475	CcSEcCtD
Atomoxetine—Fatigue—Triamcinolone—atopic dermatitis	3.85e-05	0.000474	CcSEcCtD
Atomoxetine—Fatigue—Methylprednisolone—atopic dermatitis	3.84e-05	0.000473	CcSEcCtD
Atomoxetine—Pain—Triamcinolone—atopic dermatitis	3.82e-05	0.00047	CcSEcCtD
Atomoxetine—Loss of consciousness—Prednisone—atopic dermatitis	3.8e-05	0.000468	CcSEcCtD
Atomoxetine—Urticaria—Hydrocortisone—atopic dermatitis	3.77e-05	0.000464	CcSEcCtD
Atomoxetine—Body temperature increased—Hydrocortisone—atopic dermatitis	3.75e-05	0.000461	CcSEcCtD
Atomoxetine—Abdominal pain—Hydrocortisone—atopic dermatitis	3.75e-05	0.000461	CcSEcCtD
Atomoxetine—Convulsion—Prednisone—atopic dermatitis	3.75e-05	0.000461	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	3.69e-05	0.000454	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	3.69e-05	0.000454	CcSEcCtD
Atomoxetine—Myalgia—Prednisone—atopic dermatitis	3.68e-05	0.000453	CcSEcCtD
Atomoxetine—Arthralgia—Prednisone—atopic dermatitis	3.68e-05	0.000453	CcSEcCtD
Atomoxetine—Feeling abnormal—Triamcinolone—atopic dermatitis	3.68e-05	0.000453	CcSEcCtD
Atomoxetine—Feeling abnormal—Methylprednisolone—atopic dermatitis	3.67e-05	0.000452	CcSEcCtD
Atomoxetine—Anxiety—Prednisone—atopic dermatitis	3.67e-05	0.000451	CcSEcCtD
Atomoxetine—Insomnia—Betamethasone—atopic dermatitis	3.67e-05	0.000451	CcSEcCtD
Atomoxetine—Insomnia—Dexamethasone—atopic dermatitis	3.67e-05	0.000451	CcSEcCtD
Atomoxetine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	3.66e-05	0.00045	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	3.65e-05	0.000448	CcSEcCtD
Atomoxetine—Paraesthesia—Dexamethasone—atopic dermatitis	3.64e-05	0.000448	CcSEcCtD
Atomoxetine—Paraesthesia—Betamethasone—atopic dermatitis	3.64e-05	0.000448	CcSEcCtD
Atomoxetine—Dyspepsia—Dexamethasone—atopic dermatitis	3.57e-05	0.000439	CcSEcCtD
Atomoxetine—Dyspepsia—Betamethasone—atopic dermatitis	3.57e-05	0.000439	CcSEcCtD
Atomoxetine—Urticaria—Triamcinolone—atopic dermatitis	3.55e-05	0.000436	CcSEcCtD
Atomoxetine—Urticaria—Methylprednisolone—atopic dermatitis	3.54e-05	0.000436	CcSEcCtD
Atomoxetine—Body temperature increased—Triamcinolone—atopic dermatitis	3.53e-05	0.000434	CcSEcCtD
Atomoxetine—Abdominal pain—Methylprednisolone—atopic dermatitis	3.53e-05	0.000433	CcSEcCtD
Atomoxetine—Decreased appetite—Betamethasone—atopic dermatitis	3.53e-05	0.000433	CcSEcCtD
Atomoxetine—Decreased appetite—Dexamethasone—atopic dermatitis	3.53e-05	0.000433	CcSEcCtD
Atomoxetine—Infection—Prednisone—atopic dermatitis	3.51e-05	0.000431	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Betamethasone—atopic dermatitis	3.5e-05	0.00043	CcSEcCtD
Atomoxetine—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	3.5e-05	0.00043	CcSEcCtD
Atomoxetine—Fatigue—Betamethasone—atopic dermatitis	3.5e-05	0.00043	CcSEcCtD
Atomoxetine—Fatigue—Dexamethasone—atopic dermatitis	3.5e-05	0.00043	CcSEcCtD
Atomoxetine—Shock—Prednisone—atopic dermatitis	3.47e-05	0.000427	CcSEcCtD
Atomoxetine—Pain—Betamethasone—atopic dermatitis	3.47e-05	0.000426	CcSEcCtD
Atomoxetine—Pain—Dexamethasone—atopic dermatitis	3.47e-05	0.000426	CcSEcCtD
Atomoxetine—Nervous system disorder—Prednisone—atopic dermatitis	3.46e-05	0.000426	CcSEcCtD
Atomoxetine—Tachycardia—Prednisone—atopic dermatitis	3.45e-05	0.000424	CcSEcCtD
Atomoxetine—Skin disorder—Prednisone—atopic dermatitis	3.43e-05	0.000422	CcSEcCtD
Atomoxetine—Hyperhidrosis—Prednisone—atopic dermatitis	3.41e-05	0.00042	CcSEcCtD
Atomoxetine—Asthenia—Hydrocortisone—atopic dermatitis	3.41e-05	0.000419	CcSEcCtD
Atomoxetine—Anorexia—Prednisone—atopic dermatitis	3.37e-05	0.000414	CcSEcCtD
Atomoxetine—Pruritus—Hydrocortisone—atopic dermatitis	3.36e-05	0.000413	CcSEcCtD
Atomoxetine—Feeling abnormal—Dexamethasone—atopic dermatitis	3.34e-05	0.000411	CcSEcCtD
Atomoxetine—Feeling abnormal—Betamethasone—atopic dermatitis	3.34e-05	0.000411	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Betamethasone—atopic dermatitis	3.32e-05	0.000408	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Dexamethasone—atopic dermatitis	3.32e-05	0.000408	CcSEcCtD
Atomoxetine—Diarrhoea—Hydrocortisone—atopic dermatitis	3.25e-05	0.000399	CcSEcCtD
Atomoxetine—Urticaria—Betamethasone—atopic dermatitis	3.22e-05	0.000396	CcSEcCtD
Atomoxetine—Urticaria—Dexamethasone—atopic dermatitis	3.22e-05	0.000396	CcSEcCtD
Atomoxetine—Musculoskeletal discomfort—Prednisone—atopic dermatitis	3.22e-05	0.000396	CcSEcCtD
Atomoxetine—Dizziness—Prednisolone—atopic dermatitis	3.21e-05	0.000395	CcSEcCtD
Atomoxetine—Asthenia—Triamcinolone—atopic dermatitis	3.21e-05	0.000394	CcSEcCtD
Atomoxetine—Abdominal pain—Betamethasone—atopic dermatitis	3.21e-05	0.000394	CcSEcCtD
Atomoxetine—Abdominal pain—Dexamethasone—atopic dermatitis	3.21e-05	0.000394	CcSEcCtD
Atomoxetine—Body temperature increased—Betamethasone—atopic dermatitis	3.21e-05	0.000394	CcSEcCtD
Atomoxetine—Body temperature increased—Dexamethasone—atopic dermatitis	3.21e-05	0.000394	CcSEcCtD
Atomoxetine—Asthenia—Methylprednisolone—atopic dermatitis	3.2e-05	0.000393	CcSEcCtD
Atomoxetine—Insomnia—Prednisone—atopic dermatitis	3.19e-05	0.000393	CcSEcCtD
Atomoxetine—Paraesthesia—Prednisone—atopic dermatitis	3.17e-05	0.00039	CcSEcCtD
Atomoxetine—Pruritus—Triamcinolone—atopic dermatitis	3.16e-05	0.000389	CcSEcCtD
Atomoxetine—Pruritus—Methylprednisolone—atopic dermatitis	3.15e-05	0.000388	CcSEcCtD
Atomoxetine—Dizziness—Hydrocortisone—atopic dermatitis	3.14e-05	0.000386	CcSEcCtD
Atomoxetine—Dyspepsia—Prednisone—atopic dermatitis	3.11e-05	0.000382	CcSEcCtD
Atomoxetine—Decreased appetite—Prednisone—atopic dermatitis	3.07e-05	0.000377	CcSEcCtD
Atomoxetine—Rash—Prednisolone—atopic dermatitis	3.06e-05	0.000377	CcSEcCtD
Atomoxetine—Dermatitis—Prednisolone—atopic dermatitis	3.06e-05	0.000376	CcSEcCtD
Atomoxetine—Diarrhoea—Methylprednisolone—atopic dermatitis	3.05e-05	0.000375	CcSEcCtD
Atomoxetine—Fatigue—Prednisone—atopic dermatitis	3.04e-05	0.000374	CcSEcCtD
Atomoxetine—Headache—Prednisolone—atopic dermatitis	3.04e-05	0.000374	CcSEcCtD
Atomoxetine—Constipation—Prednisone—atopic dermatitis	3.02e-05	0.000371	CcSEcCtD
Atomoxetine—Vomiting—Hydrocortisone—atopic dermatitis	3.02e-05	0.000371	CcSEcCtD
Atomoxetine—Rash—Hydrocortisone—atopic dermatitis	2.99e-05	0.000368	CcSEcCtD
Atomoxetine—Dermatitis—Hydrocortisone—atopic dermatitis	2.99e-05	0.000368	CcSEcCtD
Atomoxetine—Headache—Hydrocortisone—atopic dermatitis	2.97e-05	0.000366	CcSEcCtD
Atomoxetine—Dizziness—Triamcinolone—atopic dermatitis	2.96e-05	0.000363	CcSEcCtD
Atomoxetine—Dizziness—Methylprednisolone—atopic dermatitis	2.95e-05	0.000363	CcSEcCtD
Atomoxetine—Feeling abnormal—Prednisone—atopic dermatitis	2.91e-05	0.000358	CcSEcCtD
Atomoxetine—Asthenia—Dexamethasone—atopic dermatitis	2.91e-05	0.000358	CcSEcCtD
Atomoxetine—Asthenia—Betamethasone—atopic dermatitis	2.91e-05	0.000358	CcSEcCtD
Atomoxetine—Gastrointestinal pain—Prednisone—atopic dermatitis	2.89e-05	0.000355	CcSEcCtD
Atomoxetine—Nausea—Prednisolone—atopic dermatitis	2.89e-05	0.000355	CcSEcCtD
Atomoxetine—Pruritus—Dexamethasone—atopic dermatitis	2.87e-05	0.000353	CcSEcCtD
Atomoxetine—Pruritus—Betamethasone—atopic dermatitis	2.87e-05	0.000353	CcSEcCtD
Atomoxetine—Vomiting—Triamcinolone—atopic dermatitis	2.84e-05	0.000349	CcSEcCtD
Atomoxetine—Vomiting—Methylprednisolone—atopic dermatitis	2.84e-05	0.000349	CcSEcCtD
Atomoxetine—Nausea—Hydrocortisone—atopic dermatitis	2.82e-05	0.000347	CcSEcCtD
Atomoxetine—Rash—Triamcinolone—atopic dermatitis	2.82e-05	0.000346	CcSEcCtD
Atomoxetine—Dermatitis—Triamcinolone—atopic dermatitis	2.82e-05	0.000346	CcSEcCtD
Atomoxetine—Rash—Methylprednisolone—atopic dermatitis	2.81e-05	0.000346	CcSEcCtD
Atomoxetine—Dermatitis—Methylprednisolone—atopic dermatitis	2.81e-05	0.000345	CcSEcCtD
Atomoxetine—Urticaria—Prednisone—atopic dermatitis	2.81e-05	0.000345	CcSEcCtD
Atomoxetine—Headache—Triamcinolone—atopic dermatitis	2.8e-05	0.000344	CcSEcCtD
Atomoxetine—Headache—Methylprednisolone—atopic dermatitis	2.79e-05	0.000343	CcSEcCtD
Atomoxetine—Abdominal pain—Prednisone—atopic dermatitis	2.79e-05	0.000343	CcSEcCtD
Atomoxetine—Body temperature increased—Prednisone—atopic dermatitis	2.79e-05	0.000343	CcSEcCtD
Atomoxetine—Diarrhoea—Betamethasone—atopic dermatitis	2.77e-05	0.000341	CcSEcCtD
Atomoxetine—Diarrhoea—Dexamethasone—atopic dermatitis	2.77e-05	0.000341	CcSEcCtD
Atomoxetine—Dizziness—Betamethasone—atopic dermatitis	2.68e-05	0.00033	CcSEcCtD
Atomoxetine—Dizziness—Dexamethasone—atopic dermatitis	2.68e-05	0.00033	CcSEcCtD
Atomoxetine—Nausea—Triamcinolone—atopic dermatitis	2.65e-05	0.000326	CcSEcCtD
Atomoxetine—Nausea—Methylprednisolone—atopic dermatitis	2.65e-05	0.000326	CcSEcCtD
Atomoxetine—Vomiting—Dexamethasone—atopic dermatitis	2.58e-05	0.000317	CcSEcCtD
Atomoxetine—Vomiting—Betamethasone—atopic dermatitis	2.58e-05	0.000317	CcSEcCtD
Atomoxetine—Rash—Dexamethasone—atopic dermatitis	2.56e-05	0.000314	CcSEcCtD
Atomoxetine—Rash—Betamethasone—atopic dermatitis	2.56e-05	0.000314	CcSEcCtD
Atomoxetine—Dermatitis—Dexamethasone—atopic dermatitis	2.55e-05	0.000314	CcSEcCtD
Atomoxetine—Dermatitis—Betamethasone—atopic dermatitis	2.55e-05	0.000314	CcSEcCtD
Atomoxetine—Headache—Dexamethasone—atopic dermatitis	2.54e-05	0.000312	CcSEcCtD
Atomoxetine—Headache—Betamethasone—atopic dermatitis	2.54e-05	0.000312	CcSEcCtD
Atomoxetine—Asthenia—Prednisone—atopic dermatitis	2.53e-05	0.000311	CcSEcCtD
Atomoxetine—Pruritus—Prednisone—atopic dermatitis	2.5e-05	0.000307	CcSEcCtD
Atomoxetine—Diarrhoea—Prednisone—atopic dermatitis	2.42e-05	0.000297	CcSEcCtD
Atomoxetine—Nausea—Dexamethasone—atopic dermatitis	2.41e-05	0.000296	CcSEcCtD
Atomoxetine—Nausea—Betamethasone—atopic dermatitis	2.41e-05	0.000296	CcSEcCtD
Atomoxetine—Dizziness—Prednisone—atopic dermatitis	2.34e-05	0.000287	CcSEcCtD
Atomoxetine—Vomiting—Prednisone—atopic dermatitis	2.25e-05	0.000276	CcSEcCtD
Atomoxetine—Rash—Prednisone—atopic dermatitis	2.23e-05	0.000274	CcSEcCtD
Atomoxetine—Dermatitis—Prednisone—atopic dermatitis	2.22e-05	0.000273	CcSEcCtD
Atomoxetine—Headache—Prednisone—atopic dermatitis	2.21e-05	0.000272	CcSEcCtD
Atomoxetine—Nausea—Prednisone—atopic dermatitis	2.1e-05	0.000258	CcSEcCtD
Atomoxetine—HTR1D—GPCR downstream signaling—TAC1—atopic dermatitis	2e-05	0.000878	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—CCL27—atopic dermatitis	2e-05	0.000878	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—CCL5—atopic dermatitis	2e-05	0.000878	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—CCL17—atopic dermatitis	2e-05	0.000877	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—CCR3—atopic dermatitis	2e-05	0.000876	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—CXCR3—atopic dermatitis	1.98e-05	0.000868	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—CXCR3—atopic dermatitis	1.96e-05	0.000861	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—TAC1—atopic dermatitis	1.96e-05	0.00086	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—NPS—atopic dermatitis	1.96e-05	0.00086	CbGpPWpGaD
Atomoxetine—HTR2A—SIDS Susceptibility Pathways—CXCL8—atopic dermatitis	1.94e-05	0.000853	CbGpPWpGaD
Atomoxetine—NPY1R—GPCR downstream signaling—IL2—atopic dermatitis	1.94e-05	0.000852	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—CXCR3—atopic dermatitis	1.92e-05	0.000843	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—IL5—atopic dermatitis	1.87e-05	0.000823	CbGpPWpGaD
Atomoxetine—HTR2A—SIDS Susceptibility Pathways—IL1B—atopic dermatitis	1.86e-05	0.000818	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—IL5—atopic dermatitis	1.86e-05	0.000816	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—CCL11—atopic dermatitis	1.86e-05	0.000814	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—NGF—atopic dermatitis	1.85e-05	0.000813	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—CCL17—atopic dermatitis	1.85e-05	0.000811	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling by GPCR—CXCL8—atopic dermatitis	1.84e-05	0.00081	CbGpPWpGaD
Atomoxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	1.84e-05	0.000808	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—CCL17—atopic dermatitis	1.83e-05	0.000804	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—TAC1—atopic dermatitis	1.83e-05	0.000804	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—NPS—atopic dermatitis	1.83e-05	0.000804	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—FCER2—atopic dermatitis	1.83e-05	0.000803	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—IL5—atopic dermatitis	1.82e-05	0.000799	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—NPS—atopic dermatitis	1.82e-05	0.000797	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—TAC1—atopic dermatitis	1.82e-05	0.000797	CbGpPWpGaD
Atomoxetine—SLC6A4—SIDS Susceptibility Pathways—IL6—atopic dermatitis	1.81e-05	0.000796	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR ligand binding—CXCL10—atopic dermatitis	1.81e-05	0.000794	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—CCR5—atopic dermatitis	1.8e-05	0.000791	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—CXCR3—atopic dermatitis	1.8e-05	0.000788	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—CCL17—atopic dermatitis	1.79e-05	0.000788	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR ligand binding—CCL5—atopic dermatitis	1.79e-05	0.000787	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—CXCR3—atopic dermatitis	1.78e-05	0.000782	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—NPS—atopic dermatitis	1.78e-05	0.000781	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—TAC1—atopic dermatitis	1.78e-05	0.000781	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling by GPCR—IL2—atopic dermatitis	1.76e-05	0.000774	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—CXCR3—atopic dermatitis	1.74e-05	0.000766	CbGpPWpGaD
Atomoxetine—HTR6—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	1.74e-05	0.000764	CbGpPWpGaD
Atomoxetine—HTR1D—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	1.73e-05	0.000758	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—IL5—atopic dermatitis	1.7e-05	0.000747	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CCL22—atopic dermatitis	1.7e-05	0.000747	CbGpPWpGaD
Atomoxetine—HTR1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	1.69e-05	0.000743	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—IL5—atopic dermatitis	1.69e-05	0.000741	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—CCR3—atopic dermatitis	1.67e-05	0.000731	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—IL5—atopic dermatitis	1.65e-05	0.000726	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—KIF3A—atopic dermatitis	1.65e-05	0.000722	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—KIF3A—atopic dermatitis	1.63e-05	0.000717	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR ligand binding—CCR5—atopic dermatitis	1.61e-05	0.000709	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—CCL11—atopic dermatitis	1.61e-05	0.000707	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—KIF3A—atopic dermatitis	1.6e-05	0.000702	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—CXCL10—atopic dermatitis	1.6e-05	0.000701	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—FCER2—atopic dermatitis	1.59e-05	0.000697	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—CXCL10—atopic dermatitis	1.59e-05	0.000696	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR ligand binding—CCL5—atopic dermatitis	1.56e-05	0.000683	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—CXCL10—atopic dermatitis	1.55e-05	0.000682	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—NFKBIA—atopic dermatitis	1.53e-05	0.000671	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CCL27—atopic dermatitis	1.52e-05	0.000666	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—CCR3—atopic dermatitis	1.51e-05	0.000664	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—CCL11—atopic dermatitis	1.49e-05	0.000653	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—CMA1—atopic dermatitis	1.49e-05	0.000653	CbGpPWpGaD
Atomoxetine—SLC6A2—Transmembrane transport of small molecules—PPARA—atopic dermatitis	1.49e-05	0.000653	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—NPS—atopic dermatitis	1.48e-05	0.000652	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—TAC1—atopic dermatitis	1.48e-05	0.000652	CbGpPWpGaD
Atomoxetine—SLC6A4—Circadian rythm related genes—IL6—atopic dermatitis	1.48e-05	0.00065	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CCL22—atopic dermatitis	1.48e-05	0.000648	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—CCL11—atopic dermatitis	1.48e-05	0.000648	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—CMA1—atopic dermatitis	1.48e-05	0.000648	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—CXCR3—atopic dermatitis	1.46e-05	0.000639	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—CXCL10—atopic dermatitis	1.45e-05	0.000637	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—CCR3—atopic dermatitis	1.45e-05	0.000635	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—CMA1—atopic dermatitis	1.45e-05	0.000635	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—CCL11—atopic dermatitis	1.45e-05	0.000635	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—CXCL10—atopic dermatitis	1.44e-05	0.000632	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—CXCL10—atopic dermatitis	1.41e-05	0.000619	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR ligand binding—CCR5—atopic dermatitis	1.4e-05	0.000616	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—STAT6—atopic dermatitis	1.4e-05	0.000614	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—STAT6—atopic dermatitis	1.39e-05	0.00061	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—IL5—atopic dermatitis	1.38e-05	0.000606	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—CCL5—atopic dermatitis	1.38e-05	0.000604	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—CCL5—atopic dermatitis	1.37e-05	0.000599	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—STAT6—atopic dermatitis	1.36e-05	0.000597	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CCL17—atopic dermatitis	1.36e-05	0.000597	CbGpPWpGaD
Atomoxetine—HTR2A—SIDS Susceptibility Pathways—TNF—atopic dermatitis	1.35e-05	0.000594	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—NPS—atopic dermatitis	1.35e-05	0.000592	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—TAC1—atopic dermatitis	1.35e-05	0.000592	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—CCL5—atopic dermatitis	1.34e-05	0.000587	CbGpPWpGaD
Atomoxetine—HTR6—GPCR ligand binding—CXCL8—atopic dermatitis	1.33e-05	0.000582	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—CXCR3—atopic dermatitis	1.32e-05	0.00058	CbGpPWpGaD
Atomoxetine—SLC6A3—Transmembrane transport of small molecules—PPARA—atopic dermatitis	1.32e-05	0.000578	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CCL27—atopic dermatitis	1.32e-05	0.000578	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR ligand binding—CXCL8—atopic dermatitis	1.32e-05	0.000578	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—CCR3—atopic dermatitis	1.31e-05	0.000577	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—TAC1—atopic dermatitis	1.29e-05	0.000566	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—NPS—atopic dermatitis	1.29e-05	0.000566	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR ligand binding—CXCL8—atopic dermatitis	1.29e-05	0.000566	CbGpPWpGaD
Atomoxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	1.28e-05	0.000563	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—CXCR3—atopic dermatitis	1.26e-05	0.000555	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—IL5—atopic dermatitis	1.25e-05	0.00055	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—CCL5—atopic dermatitis	1.25e-05	0.000548	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—CCL5—atopic dermatitis	1.24e-05	0.000544	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—CCR5—atopic dermatitis	1.24e-05	0.000544	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—CCR5—atopic dermatitis	1.23e-05	0.00054	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—CCL5—atopic dermatitis	1.21e-05	0.000533	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—CCR3—atopic dermatitis	1.21e-05	0.000533	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—KIF3A—atopic dermatitis	1.21e-05	0.000532	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—CCR5—atopic dermatitis	1.2e-05	0.000529	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—CCR3—atopic dermatitis	1.2e-05	0.000529	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—IL5—atopic dermatitis	1.2e-05	0.000526	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CCL17—atopic dermatitis	1.18e-05	0.000518	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—CCR3—atopic dermatitis	1.18e-05	0.000518	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—CXCL10—atopic dermatitis	1.18e-05	0.000517	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—TAC1—atopic dermatitis	1.17e-05	0.000514	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—NPS—atopic dermatitis	1.17e-05	0.000514	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—CXCR3—atopic dermatitis	1.15e-05	0.000504	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—CCR5—atopic dermatitis	1.13e-05	0.000494	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—CCR5—atopic dermatitis	1.12e-05	0.00049	CbGpPWpGaD
Atomoxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	1.11e-05	0.000489	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CMA1—atopic dermatitis	1.1e-05	0.000481	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CCL11—atopic dermatitis	1.1e-05	0.000481	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—CCR5—atopic dermatitis	1.09e-05	0.00048	CbGpPWpGaD
Atomoxetine—HTR2A—SIDS Susceptibility Pathways—IL6—atopic dermatitis	1.09e-05	0.000479	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—CXCL8—atopic dermatitis	1.09e-05	0.000478	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—IL5—atopic dermatitis	1.09e-05	0.000478	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—TAC1—atopic dermatitis	1.08e-05	0.000475	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—NPS—atopic dermatitis	1.08e-05	0.000475	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—TAC1—atopic dermatitis	1.07e-05	0.000471	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—NPS—atopic dermatitis	1.07e-05	0.000471	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—CXCL10—atopic dermatitis	1.07e-05	0.000469	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—CXCR3—atopic dermatitis	1.06e-05	0.000466	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—CXCR3—atopic dermatitis	1.05e-05	0.000462	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—KIF3A—atopic dermatitis	1.05e-05	0.000462	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—NPS—atopic dermatitis	1.05e-05	0.000461	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—TAC1—atopic dermatitis	1.05e-05	0.000461	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—IL2—atopic dermatitis	1.04e-05	0.000457	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling by GPCR—IL6—atopic dermatitis	1.04e-05	0.000455	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—STAT6—atopic dermatitis	1.03e-05	0.000452	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—CXCR3—atopic dermatitis	1.03e-05	0.000452	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—CXCL10—atopic dermatitis	1.02e-05	0.000449	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—CCL5—atopic dermatitis	1.01e-05	0.000445	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—IL5—atopic dermatitis	1.01e-05	0.000441	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—IL5—atopic dermatitis	9.98e-06	0.000438	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—IL5—atopic dermatitis	9.77e-06	0.000429	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR ligand binding—CXCL8—atopic dermatitis	9.76e-06	0.000429	CbGpPWpGaD
Atomoxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	9.73e-06	0.000427	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—GLB1—atopic dermatitis	9.68e-06	0.000425	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—MAPK8—atopic dermatitis	9.58e-06	0.000421	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CCL11—atopic dermatitis	9.52e-06	0.000418	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CMA1—atopic dermatitis	9.52e-06	0.000418	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—ADSL—atopic dermatitis	9.28e-06	0.000407	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—CXCL10—atopic dermatitis	9.28e-06	0.000407	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—CCL5—atopic dermatitis	9.2e-06	0.000404	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—CCR5—atopic dermatitis	9.13e-06	0.000401	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—STAT6—atopic dermatitis	8.95e-06	0.000393	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CCR3—atopic dermatitis	8.94e-06	0.000392	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—GLB1—atopic dermatitis	8.9e-06	0.000391	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—CCL5—atopic dermatitis	8.8e-06	0.000386	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—CXCL10—atopic dermatitis	8.57e-06	0.000376	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—ADSL—atopic dermatitis	8.54e-06	0.000375	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—CXCL10—atopic dermatitis	8.51e-06	0.000373	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR ligand binding—CXCL8—atopic dermatitis	8.48e-06	0.000372	CbGpPWpGaD
Atomoxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	8.45e-06	0.000371	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—CXCL10—atopic dermatitis	8.33e-06	0.000366	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—CCR5—atopic dermatitis	8.29e-06	0.000364	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—CCL5—atopic dermatitis	7.99e-06	0.000351	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—TAC1—atopic dermatitis	7.96e-06	0.00035	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—NPS—atopic dermatitis	7.96e-06	0.00035	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—CCR5—atopic dermatitis	7.93e-06	0.000348	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CXCR3—atopic dermatitis	7.81e-06	0.000343	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CCR3—atopic dermatitis	7.76e-06	0.000341	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—CXCL8—atopic dermatitis	7.49e-06	0.000329	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—CXCL8—atopic dermatitis	7.44e-06	0.000326	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—IL5—atopic dermatitis	7.4e-06	0.000325	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—CCL5—atopic dermatitis	7.38e-06	0.000324	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—CCL5—atopic dermatitis	7.32e-06	0.000321	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—CXCL8—atopic dermatitis	7.28e-06	0.00032	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—CCR5—atopic dermatitis	7.2e-06	0.000316	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—CCL5—atopic dermatitis	7.17e-06	0.000315	CbGpPWpGaD
Atomoxetine—HTR6—GPCR downstream signaling—IL2—atopic dermatitis	7.16e-06	0.000314	CbGpPWpGaD
Atomoxetine—HTR1D—GPCR downstream signaling—IL2—atopic dermatitis	7.11e-06	0.000312	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	7.05e-06	0.00031	CbGpPWpGaD
Atomoxetine—HTR1B—GPCR downstream signaling—IL2—atopic dermatitis	6.96e-06	0.000305	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—NPS—atopic dermatitis	6.92e-06	0.000304	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—TAC1—atopic dermatitis	6.92e-06	0.000304	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—NGF—atopic dermatitis	6.83e-06	0.0003	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—CXCL8—atopic dermatitis	6.8e-06	0.000299	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—NGF—atopic dermatitis	6.78e-06	0.000298	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CXCR3—atopic dermatitis	6.78e-06	0.000298	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—CXCL8—atopic dermatitis	6.75e-06	0.000296	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—CCR5—atopic dermatitis	6.65e-06	0.000292	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—NGF—atopic dermatitis	6.64e-06	0.000292	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—CXCL8—atopic dermatitis	6.61e-06	0.00029	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—CCR5—atopic dermatitis	6.6e-06	0.00029	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—IL2—atopic dermatitis	6.5e-06	0.000285	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—CCR5—atopic dermatitis	6.46e-06	0.000284	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—IL2—atopic dermatitis	6.45e-06	0.000283	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—IL5—atopic dermatitis	6.43e-06	0.000282	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—IL2—atopic dermatitis	6.32e-06	0.000277	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CXCL10—atopic dermatitis	6.31e-06	0.000277	CbGpPWpGaD
Atomoxetine—NPY1R—Signaling Pathways—IL6—atopic dermatitis	6.12e-06	0.000269	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—GLB1—atopic dermatitis	5.82e-06	0.000256	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—NFKBIA—atopic dermatitis	5.64e-06	0.000247	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—NFKBIA—atopic dermatitis	5.59e-06	0.000246	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—ADSL—atopic dermatitis	5.58e-06	0.000245	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—CXCL8—atopic dermatitis	5.52e-06	0.000242	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CXCL10—atopic dermatitis	5.48e-06	0.000241	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—NFKBIA—atopic dermatitis	5.48e-06	0.00024	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CCL5—atopic dermatitis	5.43e-06	0.000239	CbGpPWpGaD
Atomoxetine—HTR2C—GPCR downstream signaling—IL2—atopic dermatitis	5.27e-06	0.000231	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—NGF—atopic dermatitis	5.03e-06	0.000221	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—CXCL8—atopic dermatitis	5.01e-06	0.00022	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CCR5—atopic dermatitis	4.9e-06	0.000215	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—CXCL8—atopic dermatitis	4.79e-06	0.00021	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—IL2—atopic dermatitis	4.79e-06	0.00021	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CCL5—atopic dermatitis	4.72e-06	0.000207	CbGpPWpGaD
Atomoxetine—HTR2A—GPCR downstream signaling—IL2—atopic dermatitis	4.58e-06	0.000201	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—NGF—atopic dermatitis	4.37e-06	0.000192	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—CXCL8—atopic dermatitis	4.35e-06	0.000191	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CCR5—atopic dermatitis	4.25e-06	0.000187	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—IL2—atopic dermatitis	4.16e-06	0.000183	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—NFKBIA—atopic dermatitis	4.15e-06	0.000182	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—CXCL8—atopic dermatitis	4.02e-06	0.000176	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—CXCL8—atopic dermatitis	3.99e-06	0.000175	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—CXCL8—atopic dermatitis	3.91e-06	0.000171	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—IL2—atopic dermatitis	3.84e-06	0.000169	CbGpPWpGaD
Atomoxetine—HTR6—Signaling by GPCR—IL6—atopic dermatitis	3.82e-06	0.000168	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—IL2—atopic dermatitis	3.81e-06	0.000167	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling by GPCR—IL6—atopic dermatitis	3.79e-06	0.000166	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—IL2—atopic dermatitis	3.73e-06	0.000164	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling by GPCR—IL6—atopic dermatitis	3.71e-06	0.000163	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—NFKBIA—atopic dermatitis	3.6e-06	0.000158	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—MAPK8—atopic dermatitis	3.54e-06	0.000155	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—MAPK8—atopic dermatitis	3.51e-06	0.000154	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—MAPK8—atopic dermatitis	3.44e-06	0.000151	CbGpPWpGaD
Atomoxetine—CYP2C19—Metabolism—PPARA—atopic dermatitis	3.14e-06	0.000138	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—CXCL8—atopic dermatitis	2.96e-06	0.00013	CbGpPWpGaD
Atomoxetine—CYP2D6—Metabolism—PPARA—atopic dermatitis	2.89e-06	0.000127	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—IL2—atopic dermatitis	2.83e-06	0.000124	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling by GPCR—IL6—atopic dermatitis	2.81e-06	0.000124	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—MAPK8—atopic dermatitis	2.6e-06	0.000114	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—CXCL8—atopic dermatitis	2.57e-06	0.000113	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—IL2—atopic dermatitis	2.46e-06	0.000108	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling by GPCR—IL6—atopic dermatitis	2.44e-06	0.000107	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—MAPK8—atopic dermatitis	2.26e-06	9.93e-05	CbGpPWpGaD
Atomoxetine—HTR6—Signaling Pathways—IL6—atopic dermatitis	2.26e-06	9.91e-05	CbGpPWpGaD
Atomoxetine—HTR1D—Signaling Pathways—IL6—atopic dermatitis	2.24e-06	9.84e-05	CbGpPWpGaD
Atomoxetine—HTR1B—Signaling Pathways—IL6—atopic dermatitis	2.19e-06	9.63e-05	CbGpPWpGaD
Atomoxetine—CYP3A4—Metabolism—PPARA—atopic dermatitis	1.89e-06	8.29e-05	CbGpPWpGaD
Atomoxetine—HTR2C—Signaling Pathways—IL6—atopic dermatitis	1.66e-06	7.3e-05	CbGpPWpGaD
Atomoxetine—HTR2A—Signaling Pathways—IL6—atopic dermatitis	1.44e-06	6.34e-05	CbGpPWpGaD
